12 West Capital Management LP 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 11:26 am Sale | 2024-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | 12 West Capital Management LP | 11,591,335 8.200% | -2,419,844 (-17.27%) | Filing |
| 2024-11-13 09:30 am Purchase | 2024-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | 12 West Capital Management LP | 14,011,179 9.900% | 2,408,191 (+20.75%) | Filing |
| 2024-02-28 4:15 pm Unchanged | 2023-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | 12 West Capital Management LP | 11,602,988 8.800% | 0 (Unchanged) | Filing |
| 2024-02-15 09:24 am Unchanged | 2023-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | 12 West Capital Management LP | 11,602,988 8.780% | 0 (Unchanged) | Filing |
| 2024-02-14 5:49 pm Purchase | 2023-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | 12 West Capital Management LP | 11,602,988 8.780% | 11,602,988 (New Position) | Filing |